P18.01 The Neuro-Oncology Branch Patient Outcomes Program (POP)

od Armstrong, T. S., Gilbert, M. R.
Izdano u Neuro Oncol (2017)

P15.01 WOUND HEALING COMPLICATIONS IN BRAIN TUMOR PATIENTS ON BEVACIZUMAB

od Ladha, H., Pawar, T., Gilbert, M.R., Armstrong, T.S.
Izdano 2014

Phase I–II clinical trial design: a state-of-the-art paradigm for dose finding

od Yan, F, Thall, P F, Lu, K H, Gilbert, M R, Yuan, Y
Izdano u Ann Oncol (2018)

O8.10 A MODEL FOR RESEARCH INITIATIVES FOR RARE CANCERS: THE COLLABORATIVE EPENDYMOMA RESEARCH NETWORK (CERN)

od Armstrong, T.S., Aldape, K., Gajjar, A., Haynes, C., Hirakawa, D., Gilbertson, R., Gilbert, M.R.
Izdano 2014

OS05.6 Final risk model for Temozolomide (TMZ)-Myelotoxicity in patients with Glioblastoma treated on NRG Oncology’s RTOG 0825

od Armstrong, T. S., Gilbert, M. R., Bondy, M., Sulman, E., Yuan, Y., Zhou, R., Vera, E., Wendland, M., Pugh, S., Scheurer, M.
Izdano u Neuro Oncol (2017)

O6.01 TARGETING THE IMMUNE CHECKPOINT NETWORK WITH MIR-138 EXERTS THERAPEUTIC EFFICACY IN MURINE MODELS OF GLIOMA

od Heimberger, A., Wei, J., Nduom, E., Kong, L., Ivan, C., Fuller, G.N., Gilbert, M.R., Conrad, C.A., Calin, G.A.
Izdano 2014

Two phase II trials of temozolomide with interferon-α2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme

od Groves, M D, Puduvalli, V K, Gilbert, M R, Levin, V A, Conrad, C A, Liu, V H, Hunter, K, Meyers, C, Hess, K R, Alfred Yung, W K
Izdano 2009

Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma

od de Groot, J. F., Gilbert, M. R., Aldape, K., Hess, K. R., Hanna, T. A., Ictech, S., Groves, M. D., Conrad, C., Colman, H., Puduvalli, V. K., Levin, V., Yung, W. K. A.
Izdano u J Neurooncol (2008)

A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients

od Raizer, J. J., Giglio, P., Hu, J., Groves, M., Merrell, R., Conrad, C., Phuphanich, S., Puduvalli, V. K., Loghin, M., Paleologos, N., Yuan, Y., Liu, D., Rademaker, A., Yung, W. K., Vaillant, B., Rudnick, J., Chamberlain, M., Vick, N., Grimm, S., Tremont-Lukats, I. W., De Groot, J., Aldape, K., Gilbert, M. R.
Izdano u J Neurooncol (2016)